Publication | Open Access
Two‐year results of a low‐dose drug‐coated balloon for revascularization of the femoropopliteal artery: Outcomes from the ILLUMENATE first‐in‐human study
91
Citations
14
References
2015
Year
The Stellarex DCB provides safe and durable clinical outcomes for treatment of femoropopliteal artery disease through 24 months.
| Year | Citations | |
|---|---|---|
Page 1
Page 1